Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Simone

Showing results (331-340 of 371) with videos related to

Pageof 38
Sort By:
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Clinical Genitourinary Cancer|June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative GroupAntoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
The Oncologist|August 1, 2020
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise CentersLucia Nappi, Margaret Ottaviano, Pasquale Rescigno, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
World Journal of Urology|October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology|June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
World Journal of Urology|November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Journal of Endourology|January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Pageof 38

Showing results (331-340 of 371) with videos related to

Sort By:
Pageof 38
BJU International|December 12, 2024
The impact of post-nephroureterectomy surgically induced chronic kidney disease on survival outcomesDhruv Puri, Margaret F Meagher, Zhenjie Wu, et al.
Clinical Genitourinary Cancer|June 10, 2023
Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative GroupAntoin Douglawi, Alireza Ghoreifi, Umberto Carbonara, et al.
The Oncologist|August 1, 2020
Management of Germ Cell Tumors During the Outbreak of the Novel Coronavirus Disease-19 Pandemic: A Survey of International Expertise CentersLucia Nappi, Margaret Ottaviano, Pasquale Rescigno, et al.
European Urology Focus|February 7, 2021
A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)Zhenjie Wu, Qi Chen, Hooman Djaladat, et al.
World Journal of Urology|October 12, 2024
Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Minerva Urology and Nephrology|June 26, 2024
Robotic distal ureterectomy for high-risk distal ureteral urothelial carcinoma: a retrospective multicenter comparative analysis (ROBUUST 2.0 collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Cancers|July 12, 2025
Prognostic Impact of Adjuvant Immunotherapy in Patients with High-Risk Upper Tract Urothelial Cancer: Results from the ROBUUST 2.0 Collaborative GroupMaxwell Otiato, Farshad Sheybaee Moghaddam, Alireza Ghoreifi, et al.
World Journal of Urology|November 18, 2024
Correction: Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 RegistryGabriele Tuderti, Riccardo Mastroianni, Flavia Proietti, et al.
Journal of Endourology|January 12, 2022
Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group)Alessandro Veccia, Umberto Carbonara, Hooman Djaladat, et al.
Urologic Oncology|May 17, 2024
Decisional and prognostic impact of diagnostic ureteroscopy in high-risk upper tract urothelial carcinoma: A multi-institutional collaborative analysis (ROBUUST collaborative group)Francesco Ditonno, Antonio Franco, Alessandro Veccia, et al.
Pageof 38